Literature DB >> 17393132

[Interferon-gamma release assays in tuberculosis diagnostics].

H Hoffmann1, G Loytved, T Bodmer.   

Abstract

Two years ago, CE certified interferon-gamma release assays (IGRA) were launched on the German market (QuantiFERON-TB Gold In-Tube and T-SPOT-TB). Since this time, a multitude of studies have analysed these assays. Guidelines have been elaborated by national expert committees of England, the USA and Switzerland. However, standards of tuberculosis diagnostics and management may vary from country to country. This statement provides practice relevant recommendations for indications, pre-analytics and the interpretation of IGRA test results under different clinical conditions. The IGRA are integrated into existing guidelines for the management of tuberculosis.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17393132     DOI： 10.1007/s00108-007-1827-8

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


  42 in total

1.  Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count.

Authors:  Keertan Dheda; Ajit Lalvani; Robert F Miller; Geoff Scott; Helen Booth; Margaret A Johnson; Alimuddin Zumla; Graham Aw Rook
Journal:  AIDS       Date:  2005-11-18       Impact factor: 4.177

2.  Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice.

Authors:  T Meier; H-P Eulenbruch; P Wrighton-Smith; G Enders; T Regnath
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

3.  Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection.

Authors:  Homayoun Shams; Stephen E Weis; Peter Klucar; Ajit Lalvani; Patrick K Moonan; Janice M Pogoda; Katie Ewer; Peter F Barnes
Journal:  Am J Respir Crit Care Med       Date:  2005-08-04       Impact factor: 21.405

4.  Tuberculin-purified protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis.

Authors:  P D Johnson; R L Stuart; M L Grayson; D Olden; A Clancy; P Ravn; P Andersen; W J Britton; J S Rothel
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

Review 5.  New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis.

Authors:  Madhukar Pai; Shriprakash Kalantri; Keertan Dheda
Journal:  Expert Rev Mol Diagn       Date:  2006-05       Impact factor: 5.225

6.  Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing.

Authors:  Madhukar Pai; Kaustubh Gokhale; Rajnish Joshi; Sandeep Dogra; Shriprakash Kalantri; Deepak K Mendiratta; Pratibha Narang; Charles L Daley; Reuben M Granich; Gerald H Mazurek; Arthur L Reingold; Lee W Riley; John M Colford
Journal:  JAMA       Date:  2005-06-08       Impact factor: 56.272

7.  Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells.

Authors:  A Lalvani; A A Pathan; H McShane; R J Wilkinson; M Latif; C P Conlon; G Pasvol; A V Hill
Journal:  Am J Respir Crit Care Med       Date:  2001-03       Impact factor: 21.405

8.  Direct costs of three models for the screening of latent tuberculosis infection.

Authors:  P Wrighton-Smith; J-P Zellweger
Journal:  Eur Respir J       Date:  2006-04-12       Impact factor: 16.671

9.  Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor.

Authors:  Aparna K Mohan; Timothy R Coté; Joel A Block; Augustine M Manadan; Jeffrey N Siegel; M Miles Braun
Journal:  Clin Infect Dis       Date:  2004-07-16       Impact factor: 9.079

10.  Screening for tuberculosis and tuberculosis infection in high-risk populations. Recommendations of the Advisory Council for the Elimination of Tuberculosis.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1995-09-08
View more
  3 in total

1.  Trends in influenza vaccination coverage rates in Germany over six seasons from 2001/02 to 2006/07.

Authors:  Patricia R Blank; Andreas U Freiburghaus; Bernhard R Ruf; Matthias M Schwenkglenks; Thomas D Szucs
Journal:  Med Klin (Munich)       Date:  2009-01-23

2.  [Severe ileocolitis refractory to standard medical treatment. A diagnostic dilemma].

Authors:  A Hofer; S Schmiedel; A W Lohse; G D Burchard
Journal:  Internist (Berl)       Date:  2008-09       Impact factor: 0.743

3.  Performance of the tuberculin skin test and interferon-gamma release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated population.

Authors:  Eun Young Kim; Ju Eun Lim; Ji Ye Jung; Ji Young Son; Kyung Jong Lee; Yoe Wun Yoon; Byung Hoon Park; Jin Wook Moon; Moo Suk Park; Young Sam Kim; Se Kyu Kim; Joon Chang; Young Ae Kang
Journal:  BMC Infect Dis       Date:  2009-12-15       Impact factor: 3.090
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.